InDevR Licenses FDA Influenza Antibodies
InDevR Licenses FDA Influenza Antibodies for VaxArray™ InDevR’s access to [...]
InDevR Licenses FDA Influenza Antibodies for VaxArray™ InDevR’s access to [...]
InDevR CEO, Dr. Kathy Rowlen, gave a presentation at HHS [...]
InDevR participated in the recent ISIRV Options IX Conference. In addition to [...]
InDevR Appoints Dawn Bitz as Chief Commercial Officer Addition Strengthens [...]
InDevR is exhibited in booth 5583 in the BioProcess Zone at the BIO [...]